{"version":"1.0","type":"link","title":"Atypical femoral fracture with early PET/CT changes from denosumab for metastatic breast cancer and transition from denosumab to zoledronic acid.","author_name":"Tan C 외","author_url":"https://prs-insight.online/author/Tan%20C","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/75284","thumbnail_width":1200,"thumbnail_height":630}